Published in Drug Law Weekly, March 6th, 2007
BioMimetic and one of the selling stockholders have granted the underwriters a 30-day option to purchase an additional 393,536 shares and 30,814 shares, respectively, of common stock to cover over-allotments, if any....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.